These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 12234460

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines.
    Hasegawa S, Abe T, Naito S, Kotoh S, Kumazawa J, Hipfner DR, Deeley RG, Cole SP, Kuwano M.
    Br J Cancer; 1995 May; 71(5):907-13. PubMed ID: 7734314
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Expression of drug resistance genes in VP-16 and mAMSA-selected human carcinoma cells.
    Matsumoto Y, Takano H, Kunishio K, Nagao S, Fojo T.
    Jpn J Cancer Res; 2001 Jul; 92(7):778-84. PubMed ID: 11473729
    [Abstract] [Full Text] [Related]

  • 5. Expression of drug resistance-related genes in head and neck squamous cell carcinomas and normal mucosa.
    Hirata S, Katoh O, Oguri T, Watanabe H, Yajin K.
    Jpn J Cancer Res; 2000 Jan; 91(1):84-90. PubMed ID: 10744048
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cells.
    Eijdems EW, Zaman GJ, de Haas M, Versantvoort CH, Flens MJ, Scheper RJ, Kamst E, Borst P, Baas F.
    Br J Cancer; 1995 Aug; 72(2):298-306. PubMed ID: 7640209
    [Abstract] [Full Text] [Related]

  • 10. Expression of mdr1, mrp, topoisomerase II alpha/beta, and cyclin A in primary or relapsed states of acute lymphoblastic leukaemias.
    Beck J, Handgretinger R, Dopfer R, Klingebiel T, Niethammer D, Gekeler V.
    Br J Haematol; 1995 Feb; 89(2):356-63. PubMed ID: 7873386
    [Abstract] [Full Text] [Related]

  • 11. Expression of multidrug resistance-associated protein (MRP) mRNA in blast cells from acute myeloid leukemia (AML) patients.
    Ross DD, Doyle LA, Schiffer CA, Lee EJ, Grant CE, Cole SP, Deeley RG, Yang W, Tong Y.
    Leukemia; 1996 Jan; 10(1):48-55. PubMed ID: 8558937
    [Abstract] [Full Text] [Related]

  • 12. Expression of MDR1/P-glycoprotein, the multidrug resistance protein MRP, and the lung-resistance protein LRP in multiple myeloma.
    Schwarzenbach H.
    Med Oncol; 2002 Jan; 19(2):87-104. PubMed ID: 12180485
    [Abstract] [Full Text] [Related]

  • 13. Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833.
    Beketic-Oreskovic L, Durán GE, Chen KG, Dumontet C, Sikic BI.
    J Natl Cancer Inst; 1995 Nov 01; 87(21):1593-602. PubMed ID: 7563202
    [Abstract] [Full Text] [Related]

  • 14. Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.
    Withoff S, de Vries EG, Keith WN, Nienhuis EF, van der Graaf WT, Uges DR, Mulder NH.
    Br J Cancer; 1996 Dec 01; 74(12):1869-76. PubMed ID: 8980384
    [Abstract] [Full Text] [Related]

  • 15. Preferential expression of a mutant allele of the amplified MDR1 (ABCB1) gene in drug-resistant variants of a human sarcoma.
    Chen KG, Lacayo NJ, Durán GE, Wang Y, Bangs CD, Rea S, Kovacs M, Cherry AM, Brown JM, Sikic BI.
    Genes Chromosomes Cancer; 2002 Aug 01; 34(4):372-83. PubMed ID: 12112526
    [Abstract] [Full Text] [Related]

  • 16. Expression of MDR1/p-glycoprotein and multidrug resistance-associated protein in childhood solid tumours.
    Oda Y, Röse I, Radig K, Wagemann W, Mittler U, Roessner A.
    Virchows Arch; 1997 Feb 01; 430(2):99-105. PubMed ID: 9083512
    [Abstract] [Full Text] [Related]

  • 17. Influence of chemosensitizers on resistance mechanisms in daunorubicin-resistant Ehrlich ascites tumour cells.
    Nielsen D, Eriksen J, Maare C, Friche E, Skovsgaard T.
    Cancer Chemother Pharmacol; 2002 Jun 01; 49(6):453-60. PubMed ID: 12107549
    [Abstract] [Full Text] [Related]

  • 18. Establishment and characterization of renal cell carcinoma cell lines with multidrug resistance.
    Yu DS, Ma CP, Chang SY.
    Urol Res; 2000 Apr 01; 28(2):86-92. PubMed ID: 10850629
    [Abstract] [Full Text] [Related]

  • 19. MDR1 and multidrug resistance-associated protein (MRP) gene expression in epithelial ovarian tumors.
    Kavallaris M, Leary JA, Barrett JA, Friedlander ML.
    Cancer Lett; 1996 Apr 19; 102(1-2):7-16. PubMed ID: 8603381
    [Abstract] [Full Text] [Related]

  • 20. Loss of amino acids 1490Lys-Ser-Lys1492 in the COOH-terminal region of topoisomerase IIalpha in human small cell lung cancer cells selected for resistance to etoposide results in an extranuclear enzyme localization.
    Wessel I, Jensen PB, Falck J, Mirski SE, Cole SP, Sehested M.
    Cancer Res; 1997 Oct 15; 57(20):4451-4. PubMed ID: 9377550
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.